Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival

Journal article

J U Gutterman, S P Richman, C M McBride, M A Burgess, S L Bartold, A Kennedy, E A Gehan, G Mavligit and E M Hersh

Recent results in cancer research, Vol.68, pp.359-362

1978

PMID: 752870

Abstract

Dacarbazine - therapeutic use

Melanoma - immunology

Humans

Melanoma - drug therapy

Neoplasm Recurrence, Local

BCG Vaccine - therapeutic use

Melanoma - surgery

Melanoma - therapy

Postoperative Complications

BCG Vaccine - administration & dosage

Melanoma - mortality

9 Record Views

Title: Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival
Creators: J U Gutterman
S P Richman
C M McBride
M A Burgess
S L Bartold
A Kennedy
E A Gehan
G Mavligit
E M Hersh
Publication Details: Recent results in cancer research, Vol.68, pp.359-362
Publisher: Germany
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 752870
Record Identifier: 991031562111102976